Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.

MLA

Wang, Yiping, et al. “Enhanced Th1-Biased Immune Efficacy of Porcine Circovirus Type 2 Cap-Protein-Based Subunit Vaccine When Coadministered with Recombinant Porcine IL-2 or GM-CSF in Mice.” Applied Microbiology & Biotechnology, vol. 99, no. 3, Feb. 2015, pp. 1155–63. EBSCOhost, https://doi.org/10.1007/s00253-014-6167-8.

APA

Wang, Y., Lu, Y., Liu, D., Wei, Y., Guo, L., Wu, H., Huang, L., Liu, J., & Liu, C. (2015). Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice. Applied Microbiology & Biotechnology, 99(3), 1155–1163. https://doi.org/10.1007/s00253-014-6167-8

Chicago

Wang, Yiping, Yuehua Lu, Dan Liu, Yanwu Wei, Longjun Guo, Hongli Wu, Liping Huang, Jianbo Liu, and Changming Liu. 2015. “Enhanced Th1-Biased Immune Efficacy of Porcine Circovirus Type 2 Cap-Protein-Based Subunit Vaccine When Coadministered with Recombinant Porcine IL-2 or GM-CSF in Mice.” Applied Microbiology & Biotechnology 99 (3): 1155–63. doi:10.1007/s00253-014-6167-8.